
Brown Forman rose 9.2% from $27.82 to $30.37, behind the S&P 500's +9.8%. Its worst day was Apr 29 (−10.3%), and its low came Mar 20 at $22.80.
Nov 11, 2025 – Nov 9, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $0.47 beat the $0.47 estimate on $1.0B revenue (est. $1.0B).
−2.1% · S&P 500 +0.1%
EPS of $0.58 beat the $0.47 estimate on $1.1B revenue (est. $1.0B).
Story events cover the past 12 months · Times ET
−6.6% · S&P 500 +0.7%
Brown Forman closed at its lowest level of the year, 18.0% below where the year started.
−2.2% · S&P 500 −1.4%
Brown Forman shares rose 12.9%, while the S&P 500 rose 0.6%.
+12.9%, the year's best day · S&P 500 +0.6%
JP Morgan moved Brown Forman from Neutral to Underweight and cut its price target from $27.00 to $23.00; shares fell 10.3%.
−10.3%, the year's worst day · S&P 500 0.0%
EPS of $0.12 missed the $0.32 estimate on $912.0M revenue (est. $879.2M).
+2.8% · S&P 500 +0.4%
EPS of $0.38 beat the $0.37 estimate on $911.0M revenue (est. $916.3M).
+3.0% · S&P 500 +0.4%
Brown Forman shares rose 7.1%, while the S&P 500 fell 1.2%.
+7.1% · S&P 500 −1.2%
Where it ended: a close of $30.37 on Nov 9, 2026. Up next: Q2 2027 earnings on Dec 3, 2026 (EPS est. $0.46, revenue est. $1.0B).
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for BF/B and SPY from Benzinga historical bars. Not investment advice.